
    
      Eligible subjects will receive 3 bi-weekly treatments (2 weeks interval) with the UltraShape
      Power device according to the study protocol.

      One random flank will be treated with one pass or remained as a control (no treatment) while
      the second flank will be treated with multiple passes.

      Subjects will return for up to 4 follow up visits: 4 weeks, 8 weeks, 12 weeks and (optional)
      24 weeks following end of treatment/s.

      Each subject will be enrolled for total expected study duration of up to 28 weeks.

      After last follow up visit, subjects who wish will receive compensation treatments (up to 3)
      on the flank who received regular treatment (single pass) or remained as a control (no
      treatment).
    
  